One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
From Patients to Consumers — The Corporatization of Ambulatory Care
doi : 10.1056/NEJMp2415483
Volume 394 No. 1 January 1, 2026
A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA
doi : 10.1056/NEJMp2517497
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
doi : 10.1056/NEJMoa2512071
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
doi : 10.1056/NEJMoa2510308
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
doi : 10.1056/NEJMoa2508681
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
doi : 10.1056/NEJMoa2514752
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas
doi : 10.1056/NEJMc2513023
